Age-appropriate compliance and completion of up to five doses of pertussis vaccine in US children

• Main Authors: Girishanthy Krishnarajah (Author), Elisabetta Malangone-Monaco (Author), Liisa Palmer (Author), Ellen Riehle (Author), Philip O. Buck (Author)
• Format: Book
• Published: Taylor & Francis Group, 2018-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: In the United States (US), diphtheria, tetanus, and acellular pertussis (DTaP) vaccination is recommended at 2, 4, and 6 months (doses 1-3), 15-18 months (dose 4), and 4-6 years (dose 5). The objective of this study (GSK study identifier: HO-14-14383) was to examine DTaP completion and c...